Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2020

03.11.2020 | Perspective

A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference

verfasst von: William C. Becker, MD, Erin E. Krebs, MD, MPH, Sara N. Edmond, PhD, Lewei A. Lin, MD, MS, Mark D. Sullivan, MD, PhD, Roger D. Weiss, MD, Adam J. Gordon, MD, MPH

Erschienen in: Journal of General Internal Medicine | Sonderheft 3/2020

Einloggen, um Zugang zu erhalten

Abstract

US military Veterans have been disproportionately impacted by the US opioid overdose crisis. In the fall of 2019, the Veterans Health Administration (VHA) convened a state-of-the-art (SOTA) conference to develop research priorities for advancing the science and clinical practice of opioid safety, including both use of opioid analgesics and managing opioid use disorder. We present the methods and consensus recommendations from the SOTA. A core group of researchers and VA clinical stakeholders defined three areas of focus for the SOTA: managing opioid use disorder, long-term opioid therapy for pain including consideration for opioid tapering, and treatment of co-occurring pain and substance use disorders. The SOTA participants divided into three workgroups and identified key questions and seminal studies related to those three areas of focus. The strongest recommendations included testing implementation strategies in the VHA for expanding access to medication treatment for opioid use disorder, testing collaborative tapering programs for patients prescribed long-term opioids, and larger trials of behavioral and exercise/movement interventions for pain among patients with substance use disorders.
Literatur
2.
Zurück zum Zitat Salas J, Scherrer JF, Schneider FD, Sullivan MD, Bucholz KK, Burroughs T, et al. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain. 2017;158(2):306-12.CrossRef Salas J, Scherrer JF, Schneider FD, Sullivan MD, Bucholz KK, Burroughs T, et al. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain. 2017;158(2):306-12.CrossRef
3.
Zurück zum Zitat Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-86.CrossRef Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-86.CrossRef
4.
Zurück zum Zitat Edelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297-304. Edelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297-304.
5.
Zurück zum Zitat Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611-2.CrossRef Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611-2.CrossRef
20.
Zurück zum Zitat Lin L, Bohnert AS, Blow FC, Gordon AJ, Ignacio RV, Kim HM, et al. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction. 2020. Lin L, Bohnert AS, Blow FC, Gordon AJ, Ignacio RV, Kim HM, et al. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction. 2020.
28.
Zurück zum Zitat Bounthavong M, Harvey MA, Wells DL, Popish SJ, Himstreet J, Oliva EM, et al. Trends in Naloxone Prescriptions Prescribed After Implementation of a National Academic Detailing Service in the Veterans Health Administration: a Preliminary Analysis. J Am Pharm Assoc (2003). 2017;57(2S):S68-S72. https://doi.org/10.1016/j.japh.2016.11.003CrossRef Bounthavong M, Harvey MA, Wells DL, Popish SJ, Himstreet J, Oliva EM, et al. Trends in Naloxone Prescriptions Prescribed After Implementation of a National Academic Detailing Service in the Veterans Health Administration: a Preliminary Analysis. J Am Pharm Assoc (2003). 2017;57(2S):S68-S72. https://​doi.​org/​10.​1016/​j.​japh.​2016.​11.​003CrossRef
30.
Zurück zum Zitat Manhapra A, Arias AJ, Ballantyne JC. The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary. Subst Abus. 2018;39(2):152-61.CrossRef Manhapra A, Arias AJ, Ballantyne JC. The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary. Subst Abus. 2018;39(2):152-61.CrossRef
31.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624-45.CrossRef Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624-45.CrossRef
32.
Zurück zum Zitat VA/DoD. Clinical practice guideline for opioid therapy for chronic pain. 2017(version 3.0). VA/DoD. Clinical practice guideline for opioid therapy for chronic pain. 2017(version 3.0).
36.
Zurück zum Zitat Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-91.CrossRef Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-91.CrossRef
38.
Zurück zum Zitat Ilgen MA, Bohnert AS, Chermack S, Conran C, Jannausch M, Trafton J, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-93.CrossRef Ilgen MA, Bohnert AS, Chermack S, Conran C, Jannausch M, Trafton J, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-93.CrossRef
40.
Zurück zum Zitat Barry DT, Beitel M, Cutter CJ, Fiellin DA, Kerns RD, Moore BA, et al. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. Drug Alcohol Depend. 2019;194:460-7.CrossRef Barry DT, Beitel M, Cutter CJ, Fiellin DA, Kerns RD, Moore BA, et al. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. Drug Alcohol Depend. 2019;194:460-7.CrossRef
42.
Zurück zum Zitat Veazie S, Mackey K, Bourne D, Peterson K. Evidence brief: Managing acute pain in patients with opioid use disorder on medication-assisted treatment. Washington DC. 2019. Veazie S, Mackey K, Bourne D, Peterson K. Evidence brief: Managing acute pain in patients with opioid use disorder on medication-assisted treatment. Washington DC. 2019.
Metadaten
Titel
A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference
verfasst von
William C. Becker, MD
Erin E. Krebs, MD, MPH
Sara N. Edmond, PhD
Lewei A. Lin, MD, MS
Mark D. Sullivan, MD, PhD
Roger D. Weiss, MD
Adam J. Gordon, MD, MPH
Publikationsdatum
03.11.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe Sonderheft 3/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06260-9

Weitere Artikel der Sonderheft 3/2020

Journal of General Internal Medicine 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.